Endovascular re-intervention versus conservative medical therapy for persistent or recurrent venous-origin chronic pelvic pain after primary ovarian vein embolization.

Song Xue¹, Fengshi Li¹, Tiandong Lu², Xin Wang¹, Jiateng Hu¹, Xinwu Lu¹, Chaoyi Cui³, Xiaobing Liu⁴

¹Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

²Institute of Research and Clinical Innovations, Neusoft Medical Systems Co., Ltd., Shanghai, China.

³Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: cuichoi8432@163.com.

⁴Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: liuxiaobing9th@outlook.com.

PubMed DOI

Abstract

INTRODUCTION: This study aims to evaluate and compare the clinical effectiveness of endovascular re-intervention versus conservative medical therapy in patients with persistent or recurrent venous-origin chronic pelvic pain (CPP) after initial endovascular embolization for pelvic venous disorders (PeVDs). METHODS: We retrospectively reviewed 79 PeVD patients with persistent or recurrent venous-or…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.